Hepatitis C and Hepatocellular Cancer: To Treat or Not to Treat
نویسندگان
چکیده
منابع مشابه
Acute hepatitis C: to treat or not to treat.
Although no randomized controlled trials have addressed this question, I recommend a 3to 6-month course of peginterferon-based therapy (with or without ribavirin) in those patients who have failed to clear acute infection. Success rates in this setting (ie, rates of sustained viral clearance) approach 90%. The importance of early treatment is clear: these success rates vastly eclipse those seen...
متن کاملEarly-stage ovarian cancer: to treat or not to treat.
Approximately one-third of patients with epithelial ovarian cancer present with localized disease confined to the ovaries or pelvis (International Federation of Gynecology and Obstetrics [FIGO] stages I and II). Although their long-term prognosis is better (10-year survival 50%–70%) than that of patients with advanced ovarian cancer (10-year survival 15%–25%), approximately 50% of women with ea...
متن کاملStage II colorectal cancer: to treat or not to treat.
The Oncologist 2005;10:332–334 www.TheOncologist.com Correspondence: Patrick G. Johnston, M.D., Ph.D., FRCP, FRCPI, Department of Oncology, Queen’s University Belfast, University Floor, Belfast City Hospital, Belfast BT9 7AB, Northern Ireland. Telephone: 44-28-90-263911; Fax: 44-28-90263744; e-mail: [email protected] Received March 8, 2005; accepted for publication March 18, 2005. ©AlphaMed Pr...
متن کاملPediatric hepatitis C infection: to treat or not to treat...what's the best for the child?
OBJECTIVES Pediatric hepatitis C mainly occurs through mother to child transmission, to date. Children usually present a mild disease, but they are not spared from its long-term complications. Thus this infection cannot be underestimated in children and intervention is necessary. Current treatment is based on the administration of pegylated-interferon associated with ribavirin, but few studies ...
متن کاملDehydration in cancer patients: to treat or not to treat.
Many patients in the terminal phase of their illness experience reduced oral intake before death, due to causes related to their cancer or its treatment. When oral intake is not adequate, dehydration and malnutrition are the obvious results. But these terminally ill patients present a challenge to healthcare providers: to rehydrate these patients or not and, if so, how? Adequate hydration level...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Liver Disease
سال: 2021
ISSN: 2046-2484,2046-2484
DOI: 10.1002/cld.1003